Details for New Drug Application (NDA): 091695
✉ Email this page to a colleague
The generic ingredient in METHYLPHENIDATE HYDROCHLORIDE is methylphenidate hydrochloride. There are thirty-two drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the methylphenidate hydrochloride profile page.
Summary for 091695
Tradename: | METHYLPHENIDATE HYDROCHLORIDE |
Applicant: | Lannett Co Inc |
Ingredient: | methylphenidate hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 091695
Physiological Effect | Central Nervous System Stimulation |
Suppliers and Packaging for NDA: 091695
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 091695 | ANDA | Lannett Company, Inc. | 62175-310 | 62175-310-37 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-310-37) |
METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 091695 | ANDA | Lannett Company, Inc. | 62175-311 | 62175-311-37 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-311-37) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 18MG | ||||
Approval Date: | Jul 9, 2013 | TE: | BX | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 27MG | ||||
Approval Date: | Jul 9, 2013 | TE: | BX | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 36MG | ||||
Approval Date: | Sep 23, 2013 | TE: | BX | RLD: | No |
Complete Access Available with Subscription